自体血补片胸膜固定术的研究进展  

Research progress on autologous blood patch pleurodesis

作　　者：黄嘉炜 梁汉平 谢锡浩[1] 林万里[1] HUANG Jiawei;LIANG Hanping;XIE Xihao;LIN Wanli(Department of Thoracic Surgery,Gaozhou People’s Hospital,Maoming,525200,Guangdong,P.R.China)

机构地区：[1]高州市人民医院胸外科,广东茂名525200

出　　处：《中国胸心血管外科临床杂志》2025年第1期136-140,共5页Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

基　　金：2021广东省科技创新战略专项基金(2021S0032)。

摘　　要：自体血补片胸膜固定术(autologous blood patch pleurodesis,ABPP)于1987年首次提出,现主要用于治疗难治性气胸和肺切除术后持续性肺漏气,也用于治疗儿童气胸和其他罕见继发性气胸。持续性肺漏气和各种原因气胸实质上均为肺泡胸膜腔瘘。通常的治疗手段为胸腔闭式引流、负压吸引、手术治疗等,对于常规保守治疗无效但又无法接受手术治疗的患者,胸膜固定术是一种可替代手术的安全有效的治疗方法。相对于其他胸膜固定术使用的粘连剂,使用自体血(即ABPP)更安全有效,而且简单、无痛、廉价,易被患者接受。但结合近年来国内外研究,ABPP的很多治疗细节尚未统一规范。为进一步研究和普及ABPP,本文对其治疗细则、有效性和安全性等进行综述。Autologous blood patch pleurodesis(ABPP)was first proposed in 1987.Now it is mainly used to treat intractable pneumothorax and persistent air leakage after pneumonectomy,and also used to treat pneumothorax in children and other rare secondary pneumothorax.Persistent air leakage and pneumothorax of various causes are essentially alveolar pleural fistula.It can usually be treated by closed thoracic drainage,continuous negative pressure suction and surgery.Pleurodesis is a safe and effective alternative to surgery for patients who have failed conventional conservative treatment and can not receive operations.Compared with other pleurodesis adhesives,autologous blood(ABPP)is safer and more effective,and it is simple,painless,cheap and easy to be accepted by patients.But in the domestic and foreign researches in recent years,many details of ABPP treatment have not been standardized.For further research and popularization of ABPP,this article reviews the detailed regulations,efficacy and safety of this technology.

关 键 词：自体血补片胸膜固定术 持续性肺漏气 气胸 综述 

分 类 号：R655[医药卫生—外科学]